Archives

  1. Healthcare and Contract Manufacturing M&A Activity

    By: Michael White In this market update, we detail recent trends in Healthcare and Contract Manufacturing M&A activity. The update highlights recent M&A trends within Healthcare and Contract Manufacturing, publicly available data on precedent transactions, and Private Equity platforms and their acquisition activity. The team at Founders has extensive experience in the Healthcare Contract Manufacturing…

    READ MORE

  2. Announced Changes from CMS Regarding the Update of Stark Law and Anti-Kickback Statute Impact both Private Equity Backed Platforms and Private Physician Practices

    By Managing Director Michael White During a flurry of activity in 2020, HHS announced changes to Stark Law and Anti-Kickback Statue (“AKS”) with an effective date of 01/19/2021 which was confirmed on 02/22/2021 as the confirmed effective date. Regarding this update, a vast majority of providers will not have to act to become compliant if…

    READ MORE

  3. Healthcare M&A Outlook for 2021

    Healthcare M&A activity continued to build on the strong momentum from Q3 as the year concluded with the largest Q4 in both deal volume and value in the past six years. Deals that had been impacted by COVID-19 saw a concerted effort to close ahead of any potential changes to taxation policies. While several of…

    READ MORE

  4. Recent Specialty Physician Practice M&A – Gastroenterology

    Founders Advisors recently advised on the sale of a multi-location physician practice within allergy, ENT and immunology in the fourth quarter of 2020.  This practice will become one of the few platform investments within the space. This transaction has given our team and firm a unique level of insight into allergy, immunology, ENT and why private…

    READ MORE

  5. Recent Healthcare M&A Market Overview

    By: Michael White Healthcare M&A activity has seen a recent increase with numerous high-profile transactions announced in the third quarter across subsectors.  First quarter deal volume was on pace year over year with overall dollar volume contracting considerably due to lower leverage utilization and availability as buyers began to evaluate risk due to COVID. The…

    READ MORE